Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • Log in
  • Subscribe
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • Subscribe
  • My alerts
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
ARTICLE, Cellular/Molecular

Agonist Trapping by GABAA Receptor Channels

Matt T. Bianchi and Robert L. Macdonald
Journal of Neuroscience 1 December 2001, 21 (23) 9083-9091; DOI: https://doi.org/10.1523/JNEUROSCI.21-23-09083.2001
Matt T. Bianchi
1Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan 48104-1687, and Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Macdonald
2Neurology,
3Molecular Physiology and Biophysics, and
4Pharmacology, Vanderbilt University, Nashville, Tennessee 37212
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    GABAA receptor channel openings outlast the duration of agonist exposure. A, Macroscopic current response of a lifted HEK293T cell expressing α1β3γ2L GABAA receptors exposed to 1 mm GABA for 400 msec (solid bar). Despite precise control of the solution bathing the cell by the concentration jump technique, the current relaxation after agonist removal requires many hundreds of milliseconds. The cell was voltage clamped at −15 mV.B, Individual openings are observed for hundreds of milliseconds after a 5 msec (arrow) pulse of 1 mm GABA delivered to an excised patch containing a few α1β3γ2L GABAA receptors. The patch was voltage clamped at −70 mV.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Bicuculline inhibited GABAAreceptor currents in the absence of GABA. A, α1β3γ2L channels open spontaneously with low probability. A 100 mm concentration of bicuculline (hatched bar) rapidly and reversibly blocked the spontaneous activity in a lifted cell expressing α1β3γ2L GABAA receptors voltage clamped at −30 mV. A transient “overshoot” current was observed after bicuculline washout (dotted line inA and B). B, α1β3γ2L GABAA receptors containing the L245S mutation in the γ2L subunit have a higher spontaneous opening probability. A 100 μm concentration of bicuculline (hatched bar) rapidly and reversibly blocked the spontaneous activity in an excised patch containing the mutant GABAA receptors voltage clamped at −30 mV. C, GABAAreceptor currents activated by direct application of alphaxalone (solid bar) were blocked by 100 μmbicuculline (hatched bar). The cell was jumped first from control solution into 10 μm alphaxalone and then back to control solution (control wash), then the same cell was jumped from control into 10 μm alphaxalone and then into 100 μm bicuculline (bicuc wash). The dotted line (in C andD) shows the smaller holding current in the presence of bicuculline. D, Inhibition of the deactivation current was also observed when 1 μm alphaxalone was used, a concentration that did not produce a rebound current.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Bicuculline failed to inhibit deactivation currents after GABA application. A, Deactivation currents after a concentration jump into 1 mm GABA (solid bar) were identical whether the cell was washed into control solution (open bar) or into 100 μm bicuculline (hatched bar).B, A 100 μm concentration of bicuculline (hatched bar) produced a small degree of inhibition in the deactivation current after activation by a lower concentration of GABA (3 μm; EC50 ∼5 μm). Thedotted line shows the smaller holding current during bicuculline wash. A portion of the trace (in the circle) is expanded to show the small effect of bicuculline wash on the deactivation current. C, The noncompetitive antagonist picrotoxin (100 μm; hatched bar) significantly inhibited deactivation currents after activation by 1 mm GABA. Note the smaller holding current during picrotoxin wash. D, The benzodiazepine diazepam (1 μm; shaded bar) potentiated deactivation currents after activation with 1 mm GABA. The dotted line shows the larger holding current in the presence of diazepam. E, Deactivation current pharmacology is summarized as the percentage of change in the weighted time constant of deactivation. The number of data points is indicated next to eachbar. Asterisks indicate significant differences compared with control deactivation rate for each condition.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Bicuculline inhibited GABAA receptor currents under conditions in which unbinding and rebinding of GABA occurs. A, A 100 μm concentration of bicuculline (hatched bar) blocked the current during a long application of 3 μm GABA (solid bar) to a lifted cell expressing α1β3γ2L GABAA receptors. The response to 3 μm GABA alone from the same cell is superimposed in gray. Note the larger current after removal of bicuculline. B, Current responses to 400 msec jumps into 1 mm GABA in the same cell before and after lifting the cell from the recording dish. Deactivation currents were inhibited during bicuculline wash (hatched bar) before the cell was lifted, and this deactivation current overlapped with that observed in the same cell after it was lifted. Currents were normalized to the amplitude at the offset of the GABA pulse. The larger vertical scale value applies to the intact cell current response.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Onset of bicuculline block is limited by GABA unbinding. A, Deactivation currents of α1β3γ2L (L245S) GABAA receptors after a concentration jump into 1 mm GABA (solid bar) were partially blocked by bicuculline (hatched bar). Cells were voltage clamped at 0 to −5 mV. The onset of block was time-dependent (the separation of deactivation currents during control wash and bicuculline wash increased with time). B, To illustrate the time course of bicuculline inhibition, the traces were subtracted (middle) for comparison with the direct effect of bicuculline (left) in the same cell. The traces are normalized and overlaid to demonstrate the slow onset rate when bicuculline was applied during deactivation (right). C, Summary chart showing the onset rate of bicuculline inhibition for various conditions. Although the time course of block was often best fit by a two exponential function, only the faster time constant is shown, which accounted for >90% of the decay. The number of cells is shown for each condition. Note the logarithmic ordinate.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Diazepam unbinding is slower than GABA unbinding. Diazepam unbinds at least as slowly as GABA from α1β3γ2L GABAA receptors. Deactivation currents are shown for applications of 3 μm GABA (solid bar) with control wash (open bar), 3 μm GABA with 1 μm diazepam wash (shaded bar), 3 μm GABA + 1 μm diazepam coapplication with control wash, and 3 μm GABA + 1 μm diazepam coapplication with 1 μm diazepam wash. Currents were normalized to the amplitude at the offset of the GABA pulse.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Diazepam unbinding is independent of channel gating. A1, In the absence of GABA, diazepam (1 μm) enhanced spontaneous activity in lifted cells expressing α1β3γ2L GABAA receptors.A2, Diazepam enhanced the response to a steady-state application of 300 nm GABA (different cell than inB1). B1, Deactivation of α1β3γ2L and α1β3γ2L(L245S) GABAA receptors after a 5 msec pulse of 1 mm GABA (arrow). Longer mean open times caused by this mutation slowed deactivation. B2, In the absence of GABA, 1 μm diazepam enhanced spontaneous activity in α1β3γ2L(L245S) GABAAreceptors. C, Summary chart showing the rate of deactivation after a 1 sec application of 1 μm diazepam was indistinguishable under different GABA-binding and intrinsic gating conditions. The number of cells is indicated inparentheses. D, A 1 sec application of 1 μm diazepam applied in the absence of GABA enhances subsequent responses to 1 μm GABA in lifted cells expressing α1β3γ2L GABAA receptors. Cells were washed with control solution for the interpulse interval.

Tables

  • Figures
    • View popup
    Table 1.

    Deactivation time constants

    DrugWashτ (msec)nDrugWashτ (msec)n
    1 μmAlphControl310.2  ± 48.741 mmGABAControl376.3  ± 56.95
    1 μm Alph100 μmBic132.7  ± 32.441 mm GABA100 μm PTX61.0  ± 15.65
    10 μmAlphControl665.0  ± 47.233 μmGABAControl283.4  ± 22.05
    10 μmAlph100 μm Bic60.8  ± 5.733 μm GABA1 μm DZP362.9  ± 21.35
    1 mm GABAControl328.3  ± 29.871 mm GABAControl318.7  ± 43.710
    1 mm GABA100 μmBic320.1  ± 31.571 mm GABA1 μm DZP435.4  ± 75.410
    3 μmGABAControl244.3  ± 32.361 mmGABAControl328.7  ± 47.64
    3 μmGABA100 μm Bic218.4  ± 27.761 mm GABA600 nm DMCM276.5  ± 42.04
    100 μmBic1-an/a8.7  ± 1.6*4100 μmBic1-bn/a6.3  ± 0.6*7
    • ↵F1-a  Effect on spontaneous activity in α1β3γ2L GABAA receptors.

    • ↵F1-b  Effect on spontaneous activity of α1β3γ2L (L245S) GABAA receptors. τ (msec) is the weighted time constant of deactivation, except for

    • ↵* which indicates the time constant of inhibition onset.

    • Alph, Alphaxalone; Bic, bicuculline.

Back to top

In this issue

The Journal of Neuroscience: 21 (23)
Journal of Neuroscience
Vol. 21, Issue 23
1 Dec 2001
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Agonist Trapping by GABAA Receptor Channels
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Agonist Trapping by GABAA Receptor Channels
Matt T. Bianchi, Robert L. Macdonald
Journal of Neuroscience 1 December 2001, 21 (23) 9083-9091; DOI: 10.1523/JNEUROSCI.21-23-09083.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Agonist Trapping by GABAA Receptor Channels
Matt T. Bianchi, Robert L. Macdonald
Journal of Neuroscience 1 December 2001, 21 (23) 9083-9091; DOI: 10.1523/JNEUROSCI.21-23-09083.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • GABAA receptor
  • deactivation
  • inverse agonist
  • GABA binding
  • concentration jump
  • diazepam

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

ARTICLE

  • Netrin-1 Is a Chemorepellent for Oligodendrocyte Precursor Cells in the Embryonic Spinal Cord
  • Selective Enhancement of Synaptic Inhibition by Hypocretin (Orexin) in Rat Vagal Motor Neurons: Implications for Autonomic Regulation
  • Amiloride-Insensitive Currents of the Acid-Sensing Ion Channel-2a (ASIC2a)/ASIC2b Heteromeric Sour-Taste Receptor Channel
Show more ARTICLE

Cellular/Molecular

  • Rod Photoreceptors Avoid Saturation in Bright Light by the Movement of the G Protein Transducin
  • Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells
  • Calcium Channel-Dependent Induction of Long-Term Synaptic Plasticity at Excitatory Golgi Cell Synapses of Cerebellum
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(JNeurosci logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.